Access to Medicine Versus Test Data Exclusivity Safeguarding Flexibilities Under International Law /
| Prif Awdur: | |
|---|---|
| Awdur Corfforaethol: | |
| Crynodeb: | XVI, 256 p. 78 illus., 56 illus. in color. text | 
| Iaith: | Saesneg | 
| Cyhoeddwyd: | Berlin, Heidelberg :
          Springer Berlin Heidelberg : Imprint: Springer,
    
        2016. | 
| Rhifyn: | 1st ed. 2016. | 
| Cyfres: | Munich Studies on Innovation and Competition,
              4 | 
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1007/978-3-662-49655-8 | 
| Fformat: | Electronig Llyfr | 
                Tabl Cynhwysion: 
            
                  - Introduction
- Test Data Exclusivity: Raison d'être
- Test Data Exclusivity and Art 39(3) TRIPS
- Test Data Exclusivity in the US and the EU
- Index of Data Exclusivity and Access (IDEAS) - Free Trade Agreements
- Index of Data Exclusivity and Access (IDEAS) - National Laws
- Test Data Exclusivity in FTAs and Access to Originator Pharmaceuticals
- Conclusions and Recommendations.